Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Ibrutinib and Venetoclax for First-Line Treatment of CLL

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Soluble Urokinase Receptor and Acute Kidney Injury

    Research output: Contribution to journalLetterResearchpeer-review

  2. Erythropoietin in Preterm Infants

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Association between Mental Disorders and Subsequent Medical Conditions

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Lipoprotein(a) Reduction in Persons with Cardiovascular Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Machine learning can identify newly diagnosed patients with CLL at high risk of infection

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Blodsygdomme

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  5. Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Original languageEnglish
JournalThe New England journal of medicine
Volume381
Issue number8
Pages (from-to)788-789
Number of pages2
ISSN0028-4793
DOIs
Publication statusPublished - 22 Aug 2019

    Research areas

  • Bridged Bicyclo Compounds, Heterocyclic, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Pyrazoles, Pyrimidines, Sulfonamides

ID: 58442118